Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

744
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
744
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Drug Clearance: Overview01:06

Drug Clearance: Overview

164
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
164
Clinical Trials01:16

Clinical Trials

8.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.4K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring pharmacy students' perceptions and confidence in using AI communication tools.

Currents in pharmacy teaching & learning·2025
Same author

Targeting Amyloid Pathology in Early Alzheimer's: The Promise of Donanemab-Azbt.

Pharmacy (Basel, Switzerland)·2025
Same author

Gene Therapy and Diabetes: A Narrative Review of Recent Advances and the Role of Multidisciplinary Healthcare Teams.

Genes·2025
Same author

Predictive Modeling of Factors Influencing Adherence to SGLT-2 Inhibitors in Ambulatory Care: Insights from Prescription Claims Data Analysis.

Pharmacy (Basel, Switzerland)·2024
Same author

Geriatric Pharmacotherapy Case Series: Chronic Obstructive Pulmonary Disease.

The Senior care pharmacist·2023
Same author

<i>Responding to</i> "Senior Care Pharmacists Must Be the Disruptive Force that Reduces Adverse Drug Events in Older People".

The Senior care pharmacist·2022

Related Experiment Video

Updated: Sep 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

2025 New Drug Update: Recent Approvals and Their Clinical Implications.

Kasper Lee1, Nadia Khartabil1

  • 1West Coast University - Center for Graduate Studies, School of Pharmacy, Los Angeles, California.

The Senior Care Pharmacist
|August 7, 2025
PubMed
Summary

Understanding new drug approvals is vital for older adults facing polypharmacy and physiological changes. This review guides healthcare professionals in optimizing pharmacotherapy and minimizing adverse drug events in geriatric patients.

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.0K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

Area of Science:

  • Geriatric Pharmacology
  • Drug Safety in Older Adults
  • Pharmacotherapy Optimization

Background:

  • Increasing prevalence of polypharmacy in older adults.
  • Age-related physiological changes impacting drug metabolism and efficacy.
  • Growing need for individualized pharmacotherapy in the geriatric population.

Purpose of the Study:

  • To synthesize the latest evidence on new drug approvals relevant to older adults.
  • To provide insights into prescribing considerations for geriatric pharmacotherapy.
  • To highlight potential drug-drug interactions and strategies for mitigating adverse effects.

Main Methods:

  • Comprehensive literature review of recent drug approvals and geriatric pharmacotherapy studies.
  • Analysis of prescribing guidelines and evidence-based recommendations.
  • Synthesis of data on drug interactions and adverse event profiles in older patients.

Main Results:

  • Identification of key new drug approvals impacting geriatric care.
  • Detailed overview of pharmacotherapeutic considerations for specific patient populations.
  • Strategies for managing polypharmacy and reducing adverse drug events.

Conclusions:

  • New drug approvals necessitate updated clinical approaches for older adults.
  • Individualized pharmacotherapy and vigilant monitoring are crucial for safe and effective medication management.
  • This review serves as a valuable resource for healthcare professionals managing geriatric pharmacotherapy.